U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
VEPSITAMAB
INN  
Official Name English
IMMUNOGLOBULIN, BISPECIFIC, ANTI-(HUMAN MUCIN 17) (HUMAN MONOCLONAL MUC17_CD3_ALT2 SINGLE-CHAIN VARIABLE FRAGMENT VH1-(GGGGS)3-VL1) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS) FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN CD3 ANTIGEN .EPSILON.-CHAIN) (HU
Preferred Name English
vepsitamab [INN]
Common Name English
Vepsitamab [WHO-DD]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 741120
Created by admin on Wed Apr 02 05:17:49 GMT 2025 , Edited by admin on Wed Apr 02 05:17:49 GMT 2025
Code System Code Type Description
INN
11822
Created by admin on Wed Apr 02 05:17:49 GMT 2025 , Edited by admin on Wed Apr 02 05:17:49 GMT 2025
PRIMARY
SMS_ID
300000009420
Created by admin on Wed Apr 02 05:17:49 GMT 2025 , Edited by admin on Wed Apr 02 05:17:49 GMT 2025
PRIMARY
FDA UNII
ZR1EEO1ZLS
Created by admin on Wed Apr 02 05:17:49 GMT 2025 , Edited by admin on Wed Apr 02 05:17:49 GMT 2025
PRIMARY
CAS
2413453-53-7
Created by admin on Wed Apr 02 05:17:49 GMT 2025 , Edited by admin on Wed Apr 02 05:17:49 GMT 2025
PRIMARY
NCI_THESAURUS
C165588
Created by admin on Wed Apr 02 05:17:49 GMT 2025 , Edited by admin on Wed Apr 02 05:17:49 GMT 2025
PRIMARY
ACTIVE MOIETY
VEPSITAMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966